Gov’t urged to elevate vaccine priority of teachers | Inquirer News

Gov’t urged to elevate vaccine priority of teachers

/ 05:10 AM April 04, 2021

The Alliance of Concerned Teachers (ACT) said the rising number of COVID-19 infections among their ranks should compel the government to elevate teachers in the vaccine priority list and provide urgent medical assistance to them. ACT said there had been a marked increase in the number of infected teachers in the National Capital Region. “By all means, teachers should be considered front-line personnel in essential sectors as they deliver education amid the pandemic. Many of those infected have contracted the virus as they performed their duties—while reporting to schools, attending DepEd (Department of Education) seminars and doing home visitation,” Raymond Basilio, secretary general of ACT, said earlier this week. Under the government’s priority list, teachers are at the second tier after health workers, senior citizens, persons with comorbidities and front-line employees in essential sectors. —Mariejo S. Ramos



For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: coronavirus pandemic, coronavirus Philippines, COVID-19 Vaccines, teachers' vaccination priority
For feedback, complaints, or inquiries, contact us.

News that matters

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.